EverSource Wealth Advisors’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56K Sell
115
-41
-26% -$609 ﹤0.01% 3818
2026
Q1
$2.4K Buy
156
+28
+22% +$466 ﹤0.01% 3580
2025
Q4
$2.31K Hold
128
﹤0.01% 3455
2025
Q3
$2.06K Sell
128
-31
-19% -$453 ﹤0.01% 3504
2025
Q2
$1.73K Sell
159
-138
-46% -$1.55K ﹤0.01% 3549
2025
Q1
$3.71K Buy
297
+182
+158% +$3K ﹤0.01% 2643
2024
Q4
$2.28K Buy
115
+41
+55% +$454 ﹤0.01% 2665
2024
Q3
$605 Buy
+74
New +$502 ﹤0.01% 2830

Other funds holding MESO

EverSource Wealth Advisors's MESO Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Mesoblast (MESO) stake by 26% in Q2 2026, selling an estimated $609 and leaving 115 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.

EverSource Wealth Advisors first reported a position in MESO in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.71K in Q1 2025. 18 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • EverSource Wealth Advisors held 115 shares of Mesoblast worth $1.56K as of Q2 2026.
  • EverSource Wealth Advisors sold 41 Mesoblast shares in Q2 2026, an estimated $609.
  • Mesoblast made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3818 holding.
  • EverSource Wealth Advisors first reported a position in Mesoblast in Q3 2024 and has held it in 8 quarters since.
  • EverSource Wealth Advisors's Mesoblast position peaked at $3.71K in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.